Clinical Trials Directory

Trials / Completed

CompletedNCT04011813

Hypotaurine Supplementation Benefits in Cryopreservation

Official Title: Hypotaurine Supplementation in Freezing and Preparation Media Improves Human Sperm DeoxyriboNucleic Acid (DNA) and Fertilizing Ability

Status
Completed
Phase
Study type
Observational
Enrollment
33 (actual)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Although it is widely used, slow freezing can induce strong functional and nuclear spermatic alterations reducing the chances of pregnancy. The study objective is to determinate the effects of the combination of hypotaurine supplementation and spermatozoa selection by Density Gradient Centrifugation (DGC) on human sperm functions and DNA quality during a freezing-thawing cycle.

Detailed description

This prospective study was performed on surplus semen after a density gradient centrifugation-frozen-thawing cycle. Samples were obtained from men undergoing routine semen analysis at the Center for Reproductive Medicine. Spermatozoa were selected by density gradient centrifugation, washed and frozen using a programmable device. Each step was performed in parallel with (H+ arm) or without (H- arm) 50mM hypotaurine supplementation. After thawing, investigator team compared for both conditions the total and progressive mobility, vitality, integrity of the acrosome, markers of Protein Kinase A (PKA) dependent capacitation intracellular signaling pathway and nuclear quality by measuring chromatin packaging, DNA fragmentation and oxidation and vacuoles presence in the spermatozoa head.

Conditions

Interventions

TypeNameDescription
OTHERHypotaurine : antioxidant and osmoregulatorHypotaurine has protective effects on sperm motility, capacitation and acrosome reaction and reduces apoptotic markers. Hypotaurine (50mM) was added in density gradient centrifugation, washing and cryopreservation media washing and cryopreservation media before spermatozoa freezing

Timeline

Start date
2014-05-01
Primary completion
2018-08-01
Completion
2019-05-01
First posted
2019-07-09
Last updated
2019-07-09

Source: ClinicalTrials.gov record NCT04011813. Inclusion in this directory is not an endorsement.